{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "17013 Guidance & Advice on Contraception 2.1.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "GUIDANCE AND ADVICE ON CONTRACEPTION"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "17013"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "2.1"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "Midwives, Obstetricians, Gynaecologists and Gynaecology Nurses"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "30 July 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "29 July 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "NICE Guidance QS129"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "9, 12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Women's and Children's"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Miss Rao, Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2610 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2612 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "n/a"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Miss Thakur, Clinical Director"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group Chair's Action"
                    },
                    {
                        "text": "30 July 2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group)"
                    },
                    {
                        "text": "August 2020"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612Trust Intranet \u2612Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "17013 Guidance & Advice on Contraception 2.1.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 13,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Mr Gangooly"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Mr Partington"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Mr Spencer"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Miss Sharma"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Mr Fiadjoe"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Miss Joshi"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Miss Dutta"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Miss Kausar"
                    },
                    {
                        "text": "Obstetrics and Gynaecology Consultant"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Lavina D'Souza"
                    },
                    {
                        "text": "Matron for Gynaecology Services"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Joanne Luck"
                    },
                    {
                        "text": "Senior Sister Gynaecology Outpatients"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Debbie Anderson"
                    },
                    {
                        "text": "Staff Nurse Gynaecology Outpatients"
                    },
                    {
                        "text": "15 May 2020"
                    },
                    {
                        "text": "Claire Fitzgerald"
                    },
                    {
                        "text": "Pharmacist"
                    },
                    {
                        "text": "15 May 2020"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) 04071 Standard Infection Prevention 04072 Hand Hygiene 06036 Guideline for Maternity Record Keeping including Documentation in Handheld Records 04272 Maternity Care 09127 Routine Postnatal Care of Women and their Babies"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Ashley May"
                    },
                    {
                        "text": "created"
                    },
                    {
                        "text": "30 August 2017"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Miss Rao"
                    },
                    {
                        "text": "Full review: clarification to points 11.3,15.0, 19.0, 21.0, 22.0"
                    },
                    {
                        "text": "30 July 2020"
                    },
                    {
                        "text": "2.1"
                    },
                    {
                        "text": "Rachel Smith"
                    },
                    {
                        "text": "Typo noted for menstruation at point 12.3"
                    },
                    {
                        "text": "21 October 2020"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 0,
                "text": "."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose....... ................................................................................................................... 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Equality Impact Assessment ........................................................................................ 4  Roles and Responsibilities.................................................................................. ......... 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Background and Introduction ...................................................................................... 4  Contraception after an Abortion.......................................................................... ......... 5  Postnatal Prescribing........................................................................................... ......... 5  Discussing Contraception\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.....\u2026 ..... 5  History taking\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026... ..... .6  Common Exclusions ........................................................................................... ......... 6  Combined Oral Contraceptive Pill........................................................................ ........ 8   Progesterone-only Pill.......................................................................................... ......... 9  Depot Injection...................................................................................................... ......... 9  Implant................................................................................................................. ......... 10  Intrauterine System\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026.\u2026. .... 10  Copper Intrauterine Device\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026. ... 11  Female Sterilisation\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026... ... 11  Male Sterilisation\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026.... ... 12"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Barrier Methods\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026....\u2026 ... 12  Emergency Contraception\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026 ... 12  Consent\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...\u2026 .. 12  Audit and Monitoring\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026.... ... 13  Staff and Training \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026........\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...\u2026. ..... 13  Approval and Implementation\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...\u2026 .. 13  References\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...... .. 14 Appendix 1 Preliminary Equality Analysis\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..\u2026\u2026\u2026\u2026\u2026........ .. 15"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Purpose"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "The purpose of this guideline is to provide guidance on the advice and provision of contraception by practitioners in obstetrics and gynaecology, especially in the abortion and postnatal care services."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "Mid and South Essex NHS Foundation Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix 1)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Roles and Responsibilities"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "The Specialist Nurse for Guidelines and Audit is responsible for ensuring clinical policies, guidelines and SOPs are evidence-based and developed in line with national guidelines and following appropriate consultation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 3.2,
                "text": "The Clinical Director is responsible for the implementation of this guideline within the directorate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "prefix": 3.3,
                "text": "The Head of Midwifery, maternity matrons and maternity managers are responsible for ensuring maternity staff are aware of the guideline and implement it."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "prefix": 3.4,
                "text": "The Obstetric Clinical Lead Consultant and Labour Ward Lead Consultant are responsible for ensuring the implementation of this guideline within the clinical setting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 0,
                "prefix": 3.5,
                "text": "All maternity staff are responsible for ensuring they are familiar with this guideline in relation to their practice and have the appropriate skills to implement this guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Background and Introduction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "An estimated 19% of pregnancies are unplanned. The median age of first intercourse is 17 for both sexes. Since 1998, the under-18 conception rate for England and Wales has dropped by 51%."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "Current contraceptive methods include Long-acting Reversible Contraception (LARC), hormonal methods, and oral and barrier methods. Oral contraceptives are the most commonly used, but LARC use has increased to 31% in 2013/14."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "The effectiveness of oral contraceptive pills and barrier methods depend on their correct use every day or each time the person has sex. The effectiveness of LARC does not rely on correct everyday use."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "Although 88% of women aged 15-44 in a heterosexual relationship report using at least one method of contraception, 185,824 abortions took place in 2015. 38% of abortions were among women who had already had one or more abortions."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Contraception after an Abortion"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Healthcare practitioners should discuss contraception with women who request an abortion and should offer a choice of all methods both at assessment and at discharge"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Practitioners should emphasise that women are fertile immediately after an abortion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Postnatal Prescribing"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Healthcare practitioners should give post-natal women information about, and offer a choice of, all contraceptive methods within 7 days of delivery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "Supporting women to make an informed choice about contraception after childbirth will reduce the risk of future unplanned pregnancies. Advice and information should be given as soon as possible after delivery because fertility may return quickly, including in women who are breastfeeding. Providing advice about contraception after childbirth also helps avoid the risk of complications associated with an inter-pregnancy interval of less than  months."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Discussing Contraception"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "When discussing contraception, give details of all contraceptive methods including:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "Long-acting reversible contraceptives that need administration less than once per month:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "Methods that depend on the person remembering to take or use them:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "Permanent methods of contraception:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "prefix": 7.5,
                "text": "Women should be informed that no method of contraception is 100% effective and, for some methods, the efficacy is based on the correct use by the patient. However, this should be compared with the risk of pregnancy in unprotected intercourse (85% per year) and for withdrawal (22% per year)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "History-taking"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "The method of contraception will depend on whether the woman wishes to get pregnant in the foreseeable future, whether she would benefit from additional, non-contraceptive, features of some methods (e.g. treatment for heavy menstrual bleeding, acne etc.) and her personal preference."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "The following factors may affect the risk/benefit ratio of some methods:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Common Exclusions"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Hormonal contraception may increase VTE risk. Systemic methods rely on liver metabolism and may be transferred to breastfed babies. Intrauterine methods will be affected by anatomy and can facilitate infection."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "If in doubt, refer to the UK Medical Eligibility Criteria Guideline, or seek senior advice."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "prefix": 9.3,
                "text": "COCP is contraindicated, or of disproportionately higher risk, in:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "POP is contraindicated, or of disproportionately higher risk, in:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 9.5,
                "text": "The depot injection is contraindicated, or of disproportionately higher risk, in:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "prefix": 9.6,
                "text": "The contraceptive implant is contraindicated, or of disproportionately higher risk, in:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "prefix": 9.7,
                "text": "The copper coil is contraindicated, or of disproportionately higher risk, in:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "prefix": 9.8,
                "text": "Hormonal intrauterine systems are contraindicated, or of disproportionately higher risk, in:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Combined Oral Contraceptive Pill (COCP) \u2018The Pill'"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "The pill contains both an estrogen and a progestogen and works by inhibiting ovulation. The pill-free/placebo week regulates menstrual bleeding. It can be used indefinitely provided that there are no contra-indications."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "The pill must be taken at the same time every day:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "text": "i.  If day 1-7 use emergency contraception"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "text": "f.  Start on same day as abortion or miscarriage"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "The pill can cause nausea, mood swings, fluid-retention and breast-tenderness (common); VTE (rare)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "The pill has a failure rate of 0.3% to 9% (in first year), depending on use."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "prefix": 10.5,
                "text": "Benefits of the pill include regulation of periods, reduced bleeding, and protection against ovarian and endometrial cancer."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 1,
                "prefix": 10.6,
                "text": "Prescribing"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "text": "(Refer to MEHT Combined Oral Contraceptive Pathway)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "text": "a.  First line (no special considerations):"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 1,
                "text": "i.  Rigevidon 30/150ug (EE/LNG)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "text": "b.  Headaches (reduce estrogen):"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 1,
                "text": "i.  Gedarel 20/150ug (EE/DSG)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 1,
                "text": "ii.  Millinette 20/75ug (EE/GSD)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "text": "c.  Mood changes or loss of libido (change progestogen):"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 1,
                "text": "i.  Yasmin 30/3000ug (EE/DRSP)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 1,
                "text": "ii.  Cilest 35/250ug (EE/NGM)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 0,
                "text": "f.  Problematic bleeding (increase estrogen or change to estradiol)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "prefix": 10.7,
                "text": "Women should have their blood pressure checked before prescribing."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "prefix": 10.8,
                "text": "The COCP should be stopped 4 weeks before elective surgery."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Progesterone-only Pill (POP) \u2018The Mini Pill'"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "The mini pill contains a progestogen and works primarily by thickening cervical mucous. At higher doses of progestogen, ovulation may be partially inhibited."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "The mini pill must be taken at the same time every day:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "Bleeding with the mini pill can be unpredictable"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "prefix": 11.4,
                "text": "The mini pill has a failure rate of 1.1% to 13% (in first year), depending on use"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "prefix": 11.5,
                "text": "Prescribing (See MEHT Formulary):"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Depot Injection"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "The depot is an injection that is metabolised slowly in the muscle and prevents ovulation. After 3-6 months of irregular bleeding, the depot can cause amenorrhoea (common)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Some women experience weight gain, PMS (common); reduced bone density (uncommon). Depression and acne are also observed. 50% of women stop by 1 year."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 0,
                "prefix": 12.3,
                "text": "There may be a delay of menstruation up to 1 year after stopping the depot."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "prefix": 12.4,
                "text": "The depot has a failure rate of 0.2% during the first year. 0.4% over 2 years."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 1,
                "prefix": 12.5,
                "text": "Prescribing:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "If the dose is delayed by more than 5 days, then test for pregnancy before repeat dose and use condoms for  days after dose."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "prefix": 12.7,
                "text": "Start within first 5 days of cycle or within 5 days post-partum (unless breastfeeding)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Implant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "The implant is a small plastic rod that is placed under the skin of the upper arm (under local anaesthetic) which secretes a progestogen to prevent ovulation. It may reduce bleeding, but can also cause irregular bleeds."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "The implant must be replaced by a suitably-trained practitioner every 3 years."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "The implant has the lowest failure rate of all contraceptives at 0.05% per year. (1:1000 per 3 years)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "There is no delay to fertility when removed."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "prefix": 13.5,
                "text": "Enzyme-inducing medications (e.g. many anticonvulsants) may reduce the effectiveness."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 1,
                "prefix": 13.6,
                "text": "Prescribing:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "prefix": 13.7,
                "text": "When to insert:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Intrauterine System (IUS)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "The IUS is a small plastic \u2018T'-shaped devices that is inserted, by a suitably-qualified practitioner, into the womb. It secretes a low dose of a progestogen to prevent implantation and can prevent fertilisation. Very little hormone is present in the circulation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "Mirena is first line treatment for Heavy Menstrual Bleeding (HMB). After 3-6 months of irregular bleeding, the Mirena coil can cause reduced bleeding (90%) or amenorrhoea (24% at 3 years). Jaydess is less likely to cause amenorrhoea (13% at 3 years)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "prefix": 14.3,
                "text": "The Mirena should be replaced every 5 years (unless fitted after the age of 45). Jaydess should be replaced every 3 years."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "prefix": 14.4,
                "text": "Complications include irregular bleeding, breast tenderness, acne and headaches (common); PID <1%, amenorrhoea (uncommon); and perforation 1:1000 (rare). 60% of women stop within 5 years."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "prefix": 14.5,
                "text": "The IUS has a failure rate of 0.2% per year (<1:100 per 5years), but has a 1:20 chance of causing an ectopic if pregnancy occurs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 1,
                "prefix": 14.6,
                "text": "Prescribing:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "prefix": 14.7,
                "text": "When to insert:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 0,
                "prefix": 14.8,
                "text": "Strings should be checked 3-6 weeks after placement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "prefix": 14.9,
                "text": "There is no delay in return to fertility after removal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Copper Intrauterine Device (IUD)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "The IUD is a small plastic \u2018T'-shaped devices that is inserted, by a suitably-qualified practitioner, into the womb. It prevents fertilisation and implantation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "The coil should be replaced every 5 or  years (depending on device). It need not be replaced after the age of 40 years."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 0,
                "prefix": 15.3,
                "text": "Complications include heavy irregular bleeding (common); PID <1% (uncommon); and perforation 1:1000 (rare). 50% of women stop within 5 years."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "prefix": 15.4,
                "text": "The IUD has a failure rate of 0.6% per year (<2:100 per 5 years)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 0,
                "prefix": 15.5,
                "text": "Prescribing (Refer to MEHT Formulary)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 0,
                "prefix": 15.6,
                "text": "When to insert:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 0,
                "prefix": 15.7,
                "text": "Strings should be checked 3-6 weeks after placement."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "prefix": 15.8,
                "text": "There is no delay in return to fertility after removal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Female Sterilisation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "Tubal ligation at laparotomy, or laparoscopic placement of Filschie Clips, prevents passage of the sperm into the uterus."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 0,
                "prefix": 16.2,
                "text": "Laparoscopic Sterilisation is no longer routinely funded by CCG at MEHT. Tubal ligation may be performed at Caesarean Section provided consent has been documented at least 2 weeks in advance."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 0,
                "prefix": 16.3,
                "text": "Complications include regret (especially if young, childless, or relationship disharmony); injury during procedure 2:1000, laparotomy 3:1000 (uncommon); death during procedure 1:12,000 (very rare)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 0,
                "prefix": 16.4,
                "text": "Failure of procedure to prevent pregnancy is 2-5:1000 at 10 years (uncommon). However, ectopic may be of greater risk if pregnancy occurs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Male Sterilisation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "Vasectomy may be performed by a suitably-qualified practitioner (including some GPs) under local anaesthetic."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "Vasectomy has a failure rate of 0.1%"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Barrier Methods"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "Barrier methods prevent the sperm from fertilising the ovum. Their efficacy depends on correct use."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 0,
                "prefix": 18.2,
                "text": "The following failure rates have been observed:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Emergency Contraception"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "Levonorgestrel, a progestogen, is licenced for emergency contraception up to 72 hours post-coitus and is 85% effective. There is some protection up to 120 hours (not licenced). Further doses, for further exposures, in the cycle are safe. COCP/Condoms are required for the remainder of the cycle."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 0,
                "prefix": 19.2,
                "text": "Ullipristal Acetate, a Selective Progesterone Receptor Modulator (SPRM), is licensed for emergency contraception up to 120 hours post-coitus. It must not be repeated within the cycle. Condoms are required for the remainder of the cycle."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 1,
                "text": "a.  ellaOne  30mg (UPA)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "prefix": 19.3,
                "text": "The copper IUD is 99% effective if used within 120 hours of coitus."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Consent"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 0,
                "prefix": 16.0,
                "text": "Women aged  and over are presumed to have capacity to make decisions about their health (including contraception and abortion)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "prefix": 16.0,
                "text": "Women aged under  should be assessed for \u2018Gillick' competency and adhere to the Fraser guidelines in respect to their capacity for decision-making. This should be clearly documented."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Audit and Monitoring"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "Audit of compliance with this guideline will be considered on an annual audit basis in accordance with the Clinical Audit Strategy Policy and the Women's and Children's annual audit work plan. The Women's and Children's Clinical Audit Group will identify a lead for the audit."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 0,
                "prefix": 21.2,
                "text": "The findings of the Women's and Children's Clinical Audit Group and an action plan with named leads and timescales will be developed to address any identified deficiencies. Performance against the action plan will be monitored by this group at subsequent meetings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 0,
                "prefix": 21.3,
                "text": "The findings of the Women's and Children's Clinical Audit Group report will be reported to the monthly Women's and Children's Directorate Governance Meeting and significant concerns relating to compliance will be entered on the local Risk Assurance Framework."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 0,
                "prefix": 21.4,
                "text": "Key findings and learning points from the audit will be submitted to the Patient Safety Group within the integrated learning report."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 0,
                "prefix": 21.5,
                "text": "Key findings and learning points will be disseminated to relevant staff."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 0,
                "prefix": 21.6,
                "text": "Abortion services to be audited on:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 0,
                "prefix": 21.7,
                "text": "Post-natal services to be audited on:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Staffing and Training"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "All midwifery and obstetric staff must attend yearly mandatory training which includes skills and drills training."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 0,
                "prefix": 22.2,
                "text": "All midwifery and obstetric staff are to ensure that their knowledge and skills are up-to date in order to complete their portfolio for appraisal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 1,
                "prefix": 22.3,
                "text": "Guideline Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 0,
                "text": "22.3.1 As an integral part of the knowledge, skills framework, staff are appraised annually to ensure competency in computer skills and the ability to access the current approved guidelines via the Trust's intranet site."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Approval and Implementation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 0,
                "prefix": 23.1,
                "text": "All policies, procedures and guidelines will be circulated clinically and professional approval confirmed by the Asset Owner prior to submission to the Controlled Document team for ratification by the Joint Document Management Group."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 0,
                "prefix": 23.2,
                "text": "It is the Guidelines and Audit Nurse's and author's responsibility to inform appropriate Maternity Services' staff of the approved policy documents when they are uploaded to the Trust's Intranets."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "text": "NICE QS129 \u2013 Contraception \u2013 2016"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 0,
                "prefix": 48.0,
                "text": "FSRH \u2013 UK Medical Eligibility Criteria for Contraceptive Use \u2013 2010 RCOG  \u2013 Management of Premenstrual Syndrome \u2013 2007"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 0,
                "text": "FSRH \u2013 Problematic Bleeding w Hormonal Contraception \u2013 2015"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 0,
                "text": "NICE CG30 \u2013 Long-acting Reversible Contraception \u2013 2005"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 0,
                "text": "RCOG Consent 3 \u2013 Female Sterilisation \u2013 2016"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "NICE CG92 \u2013 Venous thromboembolism: Reducing risks in hospital \u2013 2015 FSRH \u2013 Contraception for women >40 years \u2013 2010"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 0,
                "text": "FSRH \u2013 Venous Thromboembolism and Hormonal Contraception \u2013 2014 EBCG 7 \u2013 Care of Women Requesting Induced Abortion \u2013 2011"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 0,
                "text": "https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/570040/ Updated_Abortion_Statistics_2015.pdfand"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 0,
                "text": "Guidance and Advice on Contraception / 17013 / 2.1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": ""
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 0,
                "text": "Guidance and Advice on Contraception / 17013 / 2.1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Guidance and advice on contraception/17013 (please tick all that apply)"
            }
        },
        {
            "type": "table",
            "sequence_num": 164,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2612 A change to an existing policy"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2610 A new policy"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 165,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Full Review"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "3 Year Review"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients and Clinicians"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "See pages 1 and 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 166,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Miss Rao"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Obstetric and Gynaecology Consultant"
                    },
                    {
                        "text": "22 May 2020"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 0,
                "prefix": 15.0,
                "text": ""
            }
        }
    ]
}